Tracheotomy With and Without Dual Antiplatelet Therapy

Launched by ASKLEPIOS NEUROLOGICAL CLINIC BAD SALZHAUSEN · Sep 23, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the effects of using blood-thinning medications, called dual antiplatelet therapy, on patients who need a special breathing procedure known as a percutaneous dilatative tracheostomy (PDT). This procedure is often performed on patients who are very ill and may require long-term help with breathing. The researchers want to understand if using these medications increases the risk of bleeding or other complications during and after the tracheostomy procedure, depending on how the tracheostomy is performed.

To participate in this trial, patients must have undergone a PDT. There are no specific exclusions, so if someone meets the criteria, they may be eligible to take part. Participants in this study can expect to be closely monitored for any bleeding or complications related to the procedure. This research is important because it will help doctors understand the safest way to perform tracheostomies in patients who are on blood-thinning medications.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who underwent Percutaneous Dilational Tracheostomy
• Exclusion Criteria:
• • none